Literature DB >> 22954718

Ephrin-A5 deficiency alters sensorimotor and monoaminergic development.

Michal Sheleg1, Carrie L Yochum, George C Wagner, Renping Zhou, Jason R Richardson.   

Abstract

The Eph receptors and their ligands, the ephrins, play an important role during neural development. In particular, ephrin-A5 is highly expressed in the developing nervous system in several brain regions including the olfactory bulb, frontal cortex, striatum and hypothalamus. Although a number of studies have characterized the expression of ephrin-A5 in these regions, very little is known about the functional consequences that might follow alterations in the expression of this ligand. Previously, we demonstrated that ephrin-A5 acts as a guidance molecule regulating the trajectory of the ascending midbrain dopaminergic pathways. In light of this finding and the critical role of dopamine in modulating a number of behaviors, we sought to determine whether loss of ephrin-A5 altered neurobehavioral development. Our results indicate that ephrin-A5-null mice exhibit delays in reaching developmental milestones and in the maturation of motor skills. In addition, they exhibit increased locomotor activity and reduced levels of brain monoamines. Therefore, we conclude that ephrin-A5 expression appears to be critical for proper development of central monoaminergic pathways and that its loss results in a number of neurodevelopmental abnormalities. Because alterations in monoamine function are associated with a variety of neurodevelopmental disorders, these data suggest that further study on the potential role of ephrin-A5 in such disorders is warranted.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22954718      PMCID: PMC3482281          DOI: 10.1016/j.bbr.2012.08.032

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  43 in total

1.  VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.

Authors:  N Takahashi; L L Miner; I Sora; H Ujike; R S Revay; V Kostic; V Jackson-Lewis; S Przedborski; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Axonal ephrin-As and odorant receptors: coordinate determination of the olfactory sensory map.

Authors:  Tyler Cutforth; Laurie Moring; Monica Mendelsohn; Adriana Nemes; Nirao M Shah; Michelle M Kim; Jonas Frisén; Richard Axel
Journal:  Cell       Date:  2003-08-08       Impact factor: 41.582

Review 3.  Axon guidance molecules in vascular patterning.

Authors:  Ralf H Adams; Anne Eichmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03-31       Impact factor: 10.005

Review 4.  Non-SH2/PDZ reverse signaling by ephrins.

Authors:  Ira O Daar
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

5.  Ephrin-A5 (AL-1/RAGS) is essential for proper retinal axon guidance and topographic mapping in the mammalian visual system.

Authors:  J Frisén; P A Yates; T McLaughlin; G C Friedman; D D O'Leary; M Barbacid
Journal:  Neuron       Date:  1998-02       Impact factor: 17.173

6.  Brain dopamine transporter levels in treatment and drug naïve adults with ADHD.

Authors:  Nora D Volkow; Gene-Jack Wang; Jeffrey Newcorn; Joanna S Fowler; Frank Telang; Mary V Solanto; Jean Logan; Christopher Wong; Yeming Ma; James M Swanson; Kurt Schulz; Kith Pradhan
Journal:  Neuroimage       Date:  2006-11-27       Impact factor: 6.556

7.  Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development.

Authors:  Q Y Zhou; C J Quaife; R D Palmiter
Journal:  Nature       Date:  1995-04-13       Impact factor: 49.962

8.  Ephrin-A5 regulates the formation of the ascending midbrain dopaminergic pathways.

Authors:  Margaret A Cooper; Kazuto Kobayashi; Renping Zhou
Journal:  Dev Neurobiol       Date:  2009-01       Impact factor: 3.964

9.  Astrocyte-specific disruption of SynCAM1 signaling results in ADHD-like behavioral manifestations.

Authors:  Ursula S Sandau; Zefora Alderman; Gabriel Corfas; Sergio R Ojeda; Jacob Raber
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

Review 10.  Neurobiology of depression: an integrated view of key findings.

Authors:  V Maletic; M Robinson; T Oakes; S Iyengar; S G Ball; J Russell
Journal:  Int J Clin Pract       Date:  2007-10-17       Impact factor: 2.503

View more
  11 in total

1.  Ephrin-A5 regulates inter-male aggression in mice.

Authors:  Michal Sheleg; Carrie L Yochum; Jason R Richardson; George C Wagner; Renping Zhou
Journal:  Behav Brain Res       Date:  2015-03-06       Impact factor: 3.332

2.  Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide.

Authors:  Eric E Beier; Matthew Neal; Gelerah Alam; Melissa Edler; Long-Jun Wu; Jason R Richardson
Journal:  Neurobiol Dis       Date:  2017-08-18       Impact factor: 5.996

3.  Decreased maternal behavior and anxiety in ephrin-A5-/- mice.

Authors:  M Sheleg; Q Yu; C Go; G C Wagner; A W Kusnecov; R Zhou
Journal:  Genes Brain Behav       Date:  2016-09-22       Impact factor: 3.449

4.  Prenatal cigarette smoke exposure causes hyperactivity and aggressive behavior: role of altered catecholamines and BDNF.

Authors:  Carrie Yochum; Shannon Doherty-Lyon; Carol Hoffman; Muhammad M Hossain; Judith T Zelikoff; Jason R Richardson
Journal:  Exp Neurol       Date:  2014-01-30       Impact factor: 5.330

5.  The Ephrin-A5/EphA4 Interaction Modulates Neurogenesis and Angiogenesis by the p-Akt and p-ERK Pathways in a Mouse Model of TLE.

Authors:  Yi Shu; Bo Xiao; Qian Wu; Tiantian Liu; Yang Du; Haiyun Tang; Si Chen; Li Feng; Lili Long; Yi Li
Journal:  Mol Neurobiol       Date:  2014-12-11       Impact factor: 5.590

Review 6.  Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review.

Authors:  Javier Quintero; José R Gutiérrez-Casares; Cecilio Álamo
Journal:  Neurol Ther       Date:  2022-08-11

7.  Developmental Deltamethrin Exposure Causes Persistent Changes in Dopaminergic Gene Expression, Neurochemistry, and Locomotor Activity in Zebrafish.

Authors:  Tiffany S Kung; Jason R Richardson; Keith R Cooper; Lori A White
Journal:  Toxicol Sci       Date:  2015-04-24       Impact factor: 4.849

8.  Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice.

Authors:  Alexander I Son; Michal Sheleg; Margaret A Cooper; Yuhai Sun; Norman J Kleiman; Renping Zhou
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

9.  Early-life lead exposure recapitulates the selective loss of parvalbumin-positive GABAergic interneurons and subcortical dopamine system hyperactivity present in schizophrenia.

Authors:  K H Stansfield; K N Ruby; B D Soares; J L McGlothan; X Liu; T R Guilarte
Journal:  Transl Psychiatry       Date:  2015-03-10       Impact factor: 6.222

10.  Comparative Proteomic Analysis of Carbonylated Proteins from the Striatum and Cortex of Pesticide-Treated Mice.

Authors:  Christina Coughlan; Douglas I Walker; Kelly M Lohr; Jason R Richardson; Laura M Saba; W Michael Caudle; Kristofer S Fritz; James R Roede
Journal:  Parkinsons Dis       Date:  2015-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.